These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32722819)

  • 21. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
    Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha.
    Pruhova S; Ek J; Lebl J; Sumnik Z; Saudek F; Andel M; Pedersen O; Hansen T
    Diabetologia; 2003 Feb; 46(2):291-5. PubMed ID: 12627330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maturity-onset diabetes of the young (MODY): an update.
    Anık A; Çatlı G; Abacı A; Böber E
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
    Karlsson E; Shaat N; Groop L
    Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of maturity-onset diabetes of the young (MODY) genes in Thais with early-onset type 2 diabetes mellitus.
    Plengvidhya N; Boonyasrisawat W; Chongjaroen N; Jungtrakoon P; Sriussadaporn S; Vannaseang S; Banchuin N; Yenchitsomanus PT
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):847-53. PubMed ID: 18811724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient perspectives on the diagnostic journey to a monogenic diabetes diagnosis: Barriers and facilitators.
    Guan Y; Maloney KA; Pollin TI
    J Genet Couns; 2020 Dec; 29(6):1106-1113. PubMed ID: 32162750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
    Gloyn AL; Faber JH; Malmodin D; Thanabalasingham G; Lam F; Ueland PM; McCarthy MI; Owen KR; Baunsgaard D
    PLoS One; 2012; 7(7):e40962. PubMed ID: 22859960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M; Nacarkahya G
    J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
    Giuffrida FMA; Moises RS; Weinert LS; Calliari LE; Manna TD; Dotto RP; Franco LF; Caetano LA; Teles MG; Lima RA; Alves C; Dib SA; Silveiro SP; Dias-da-Silva MR; Reis AF;
    Diabetes Res Clin Pract; 2017 Jan; 123():134-142. PubMed ID: 28012402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2).
    Gregory JM; Smith TJ; Slaughter JC; Mason HR; Hughey CC; Smith MS; Kandasamy B; Greeley SAW; Philipson LH; Naylor RN; Letourneau LR; Abumrad NN; Cherrington AD; Moore DJ
    Diabetes; 2019 Aug; 68(8):1565-1576. PubMed ID: 31092478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?
    Timsit J; Saint-Martin C; Dubois-Laforgue D; Bellanné-Chantelot C
    Can J Diabetes; 2016 Oct; 40(5):455-461. PubMed ID: 27103109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
    McDonald TJ; Shields BM; Lawry J; Owen KR; Gloyn AL; Ellard S; Hattersley AT
    Diabetes Care; 2011 Aug; 34(8):1860-2. PubMed ID: 21700917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients.
    Hwang JS; Shin CH; Yang SW; Jung SY; Huh N
    Diabetes Res Clin Pract; 2006 Oct; 74(1):75-81. PubMed ID: 16632067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
    Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
    Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
    Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
    Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substantial proportion of MODY among multiplex families participating in a Type 1 diabetes prediction programme.
    Petruzelkova L; Dusatkova P; Cinek O; Sumnik Z; Pruhova S; Hradsky O; Vcelakova J; Lebl J; Kolouskova S
    Diabet Med; 2016 Dec; 33(12):1712-1716. PubMed ID: 26641800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?
    Majidi S; Fouts A; Pyle L; Chambers C; Armstrong T; Wang Z; Batish SD; Klingensmith G; Steck AK
    Diabetes Technol Ther; 2018 Feb; 20(2):106-112. PubMed ID: 29355436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.